Categories: Bone metabolism, Cytology & Genetics, Endocrinology,  Immunology, Infectious disease, Neurodegeneration,  Oncology

With headquarters in Brno, Czech Republic, BioVendor R&D focuses on the development, production and distribution of immunodiagnostic and molecular diagnostic products. Their R&D team is behind the development of almost 200 ELISA kits for the diagnosis of serious diseases, and the new fastGEN diagnostic kits based on NGS technology.

By cooperating with research and scientific institutions and with membership in consortiums, they direct scientific activities towards the needs of laboratory medicine. Their current focus is the diagnostic potential of NGS and the introduction of automated solutions for innovative biomarkers.